| Age | Single dose of the drug |
| from 3 to 6 years | 50 mg (1 tablet of 50 mg) |
| from 6 to 12 years | 100 mg (2 tablets of 50 mg or 1 tablet of 100 mg) |
| over 12 years and adults | 200 mg (4 tablets of 50 mg or 2 tablets of 100 mg) |
| Indication | Scheme of drug administration |
| In children from 3 years of age and adults: |
| Nonspecific prevention during the epidemic of influenza and other ARVI | in a single dose 2 times a week for 3 weeks. |
| Nonspecific prophylaxis in direct contact with patients with influenza and other ARVI | in a single dose once a day for 10-14 days. |
| Treatment of influenza and other ARVI | per day (every 6 hours) for 5 days. |
| Complex therapy of chronic bronchitis, pneumonia and recurrent herpetic infection | in a single dose 4 times in a single dose 4 times a day (every 6 hours) for 5-7 days, then a single dose 2 times a week for 4 weeks. |
| Preventive maintenance after operational infectious complications | in a single dose for 2 days before the operation, then on days 2 and 5 after the operation. |